Acadian Asset Management
TCON

Acadian Asset Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Acadian Asset Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,695
Closed -$176K – 1941
2024
Q1 		$176K Hold
20,695
– – ﹤0.01% 1201
2023
Q4 		$72K Buy
+20,695
New +$72.8K ﹤0.01% 1409
2022
Q1 		– Sell
-1,026
Closed -$55K – 1855
2021
Q4 		$55K Buy
1,026
+322
+46% +$20.5K ﹤0.01% 1473
2021
Q3 		$53K Sell
704
-970
-58% -$82.1K ﹤0.01% 1545
2021
Q2 		$217K Buy
1,674
+474
+40% +$65.6K ﹤0.01% 1414
2021
Q1 		$197K Buy
+1,200
New +$231K ﹤0.01% 1509
2018
Q4 		– Sell
-30
Closed -$12K – 1863
2018
Q3 		$12K Hold
30
– – ﹤0.01% 1546
2018
Q2 		$16K Sell
30
-2
-6% -$1.06K ﹤0.01% 1548
2018
Q1 		$15K Buy
+32
New +$17.5K ﹤0.01% 1518

Other funds holding TCON

GPFA
Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return

Acadian Asset Management's TCON Position: Q2 2024 in Review

Acadian Asset Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 20,695 shares — an estimated $176K sold.

Acadian Asset Management first reported a position in TCON in Q1 2018 and held it in 9 quarters. The position peaked at $217K in Q2 2021. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.

  • Acadian Asset Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Acadian Asset Management sold 20,695 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $176K.
  • Acadian Asset Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
  • Acadian Asset Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $217K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Acadian Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.